Alex Schriver
Alex Schriver is a prominent figure in the pharmaceutical industry, serving as a spokesperson for the Pharmaceutical Research and Manufacturers of America (PhRMA). He is known for advocating against government price controls on medications, arguing that such policies could stifle innovation and reduce the availability of new treatments for patients. Recently, he made headlines by publicly opposing President Donald Trump's decree aimed at significantly lowering drug prices, stating that it would be detrimental to American patients and the overall healthcare system.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Canada | 2 | 5.00 | 0.12% | +0% | 38,005,238 | 46,862 | $1,700,000 | 2,096$ |
| Totals | 2 | 38,005,238 | 46,862 | $1,700,000 | 2,096$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Canada:
PhRMA senior vice-president Alex Schriver said in a statement that policymakers should rein in health care middlemen driving up costs for Americans.
5
Canada:
Alex Schriver, spokesman for industry group PhRMA, expressed concerns that tariffs could increase the chance of shortages.
5
Spain:
Alex Schriver stated that government price fixing is harmful to American patients.
4